FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2894788616> ?p ?o ?g. }

• W2894788616 endingPage "1229" @default.
• W2894788616 startingPage "1223" @default.
• W2894788616 abstract "Background Patients with colon cancer often present with obstruction. Large series have reported obstruction among the high-risk features, yet prospective data on its specific prognostic influence are lacking. We hypothesized that obstruction is an independent risk factor for poor prognosis in patients with stage III colon cancer. Methods N0147 was a trial conducted between 2004 and 2009 that randomly assigned patients with stage III colon cancer to adjuvant regimens of folinic acid (leucovorin calcium), fluorouracil, and oxaliplatin or fluorouracil, leucovorin, and irinotecan, with or without cetuximab. Patient-level data from the control chemotherapy-only arms were obtained. Patient, tumor, and treatment characteristics were abstracted. Disease-free survival and overall survival were estimated by the Kaplan-Meier method. Proportions were compared by χ2 and Fisher exact tests. Univariable and multivariable survival analyses were performed using Cox proportional hazards models. Results Of 1,543 patients with stage III colon cancer, 250 (16.2%) presented with obstruction. Patients with obstruction were equally likely to complete 12 cycles of adjuvant chemotherapy (75.9% vs 77.1%, P = .6). With median follow-up time of 30.9 months among survivors, five-year overall survival and disease-free survival were worse among patients with obstruction (overall survival 67.7% vs 78.0%, P < .001; disease-free survival 53.9% vs 67.0%, P < .0001). On multivariable analysis, obstruction remained significantly associated with worse survival after adjusting for T stage, N stage, performance status, age, sex, histologic grade, and body mass index (overall survival hazard ratio 1.57, 95% confidence interval 1.12–2.20, P = .001; disease-free survival 1.52, 95% confidence interval 1.18–1.95, P < .001). Conclusion In this prospectively followed cohort of patients with stage III colon cancer treated with adjuvant chemotherapy, obstruction was associated with recurrence and worse survival. Moreover, this effect was independent of T and N stage and histologic grade. These results suggest that obstruction should be incorporated into novel risk-stratification models." @default.
• W2894788616 created "2018-10-12" @default.
• W2894788616 creator A5038987271 @default.
• W2894788616 creator A5053712180 @default.
• W2894788616 creator A5053992102 @default.
• W2894788616 creator A5064029009 @default.
• W2894788616 creator A5064525249 @default.
• W2894788616 creator A5074882255 @default.
• W2894788616 creator A5082413346 @default.
• W2894788616 creator A5089463509 @default.
• W2894788616 creator A5090404605 @default.
• W2894788616 date "2018-12-01" @default.
• W2894788616 modified "2023-10-11" @default.
• W2894788616 title "Obstruction predicts worse long-term outcomes in stage III colon cancer: A secondary analysis of the N0147 trial" @default.
• W2894788616 cites W1506680628 @default.
• W2894788616 cites W1601779670 @default.
• W2894788616 cites W1972217566 @default.
• W2894788616 cites W1984809829 @default.
• W2894788616 cites W1997084004 @default.
• W2894788616 cites W2037339308 @default.
• W2894788616 cites W2044910217 @default.
• W2894788616 cites W2045970856 @default.
• W2894788616 cites W2064903822 @default.
• W2894788616 cites W2070291618 @default.
• W2894788616 cites W2075943857 @default.
• W2894788616 cites W2083005207 @default.
• W2894788616 cites W2085073818 @default.
• W2894788616 cites W2092834413 @default.
• W2894788616 cites W2103663786 @default.
• W2894788616 cites W2105230715 @default.
• W2894788616 cites W2121113526 @default.
• W2894788616 cites W2123105952 @default.
• W2894788616 cites W2123261413 @default.
• W2894788616 cites W2132352600 @default.
• W2894788616 cites W2137989130 @default.
• W2894788616 cites W2144495943 @default.
• W2894788616 cites W2146894502 @default.
• W2894788616 cites W2159342260 @default.
• W2894788616 cites W2161762351 @default.
• W2894788616 cites W2168111444 @default.
• W2894788616 cites W2169927065 @default.
• W2894788616 cites W2235523093 @default.
• W2894788616 cites W2278216384 @default.
• W2894788616 cites W2293962048 @default.
• W2894788616 cites W2321309639 @default.
• W2894788616 cites W2573152477 @default.
• W2894788616 cites W2760798018 @default.
• W2894788616 cites W3175600547 @default.
• W2894788616 doi "https://doi.org/10.1016/j.surg.2018.06.044" @default.
• W2894788616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30297240" @default.
• W2894788616 hasPublicationYear "2018" @default.
• W2894788616 type Work @default.
• W2894788616 sameAs 2894788616 @default.
• W2894788616 citedByCount "18" @default.
• W2894788616 countsByYear W28947886162020 @default.
• W2894788616 countsByYear W28947886162021 @default.
• W2894788616 countsByYear W28947886162022 @default.
• W2894788616 countsByYear W28947886162023 @default.
• W2894788616 crossrefType "journal-article" @default.
• W2894788616 hasAuthorship W2894788616A5038987271 @default.
• W2894788616 hasAuthorship W2894788616A5053712180 @default.
• W2894788616 hasAuthorship W2894788616A5053992102 @default.
• W2894788616 hasAuthorship W2894788616A5064029009 @default.
• W2894788616 hasAuthorship W2894788616A5064525249 @default.
• W2894788616 hasAuthorship W2894788616A5074882255 @default.
• W2894788616 hasAuthorship W2894788616A5082413346 @default.
• W2894788616 hasAuthorship W2894788616A5089463509 @default.
• W2894788616 hasAuthorship W2894788616A5090404605 @default.
• W2894788616 hasConcept C10515644 @default.
• W2894788616 hasConcept C121608353 @default.
• W2894788616 hasConcept C126322002 @default.
• W2894788616 hasConcept C141071460 @default.
• W2894788616 hasConcept C207103383 @default.
• W2894788616 hasConcept C2779804826 @default.
• W2894788616 hasConcept C2779998722 @default.
• W2894788616 hasConcept C2780259306 @default.
• W2894788616 hasConcept C2780962732 @default.
• W2894788616 hasConcept C44249647 @default.
• W2894788616 hasConcept C50382708 @default.
• W2894788616 hasConcept C526805850 @default.
• W2894788616 hasConcept C71924100 @default.
• W2894788616 hasConcept C90924648 @default.
• W2894788616 hasConceptScore W2894788616C10515644 @default.
• W2894788616 hasConceptScore W2894788616C121608353 @default.
• W2894788616 hasConceptScore W2894788616C126322002 @default.
• W2894788616 hasConceptScore W2894788616C141071460 @default.
• W2894788616 hasConceptScore W2894788616C207103383 @default.
• W2894788616 hasConceptScore W2894788616C2779804826 @default.
• W2894788616 hasConceptScore W2894788616C2779998722 @default.
• W2894788616 hasConceptScore W2894788616C2780259306 @default.
• W2894788616 hasConceptScore W2894788616C2780962732 @default.
• W2894788616 hasConceptScore W2894788616C44249647 @default.
• W2894788616 hasConceptScore W2894788616C50382708 @default.
• W2894788616 hasConceptScore W2894788616C526805850 @default.
• W2894788616 hasConceptScore W2894788616C71924100 @default.
• W2894788616 hasConceptScore W2894788616C90924648 @default.
• W2894788616 hasIssue "6" @default.
• W2894788616 hasLocation W28947886161 @default.

• next